Literature DB >> 16015221

Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock.

Diane L Carroll1, Glenys A Hamilton.   

Abstract

BACKGROUND: The success of the implanted cardioverter defibrillator (ICD) in prolonging the life of patients with arrhythmia suggests a need to assess quality of life (QOL), especially in those who receive an ICD shock.
OBJECTIVES: The purpose of this study was to compare QOL in a group who received an ICD shock with a group who did not receive an ICD shock during the first year.
METHODS: Fifty-nine subjects, 42 men and 17 women with a mean age 63 years, completed the Medical Outcomes Study Short Form-36, Ferrans and Powers QOL Index, Profile of Mood States at implantation and 1 year, and the Brodsky ICD Questionnaire at 1 year.
RESULTS: Thirty-seven percent received an ICD shock. Those in the shock group had worse mental health ( P < or = .04) and vitality scores ( P < or = .03) on the Short Form-36, increased anxiety ( P < or = .015), fatigue ( P < or = .005), and psychologic distress ( P < or = .02), as measured by Profile of Mood States, compared with the no shock group at 1 year.
CONCLUSIONS: Shocked ICD recipients demonstrate mental health concerns.

Entities:  

Mesh:

Year:  2005        PMID: 16015221     DOI: 10.1016/j.hrtlng.2004.10.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  17 in total

Review 1.  Informed consent in cardiac resynchronization therapy: what should be said?

Authors:  Daniel B Kramer; Dan W Brock; Usha B Tedrow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-09

Review 2.  Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here?

Authors:  Mirela Habibović; Matthew M Burg; Susanne S Pedersen
Journal:  Pacing Clin Electrophysiol       Date:  2013-02-25       Impact factor: 1.976

Review 3.  Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?

Authors:  Andrew Ho; Ramin Assadi; Sudha M Pai; Ramdas G Pai
Journal:  Curr Cardiol Rep       Date:  2006-09       Impact factor: 2.931

Review 4.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

5.  Prevention of inappropriate ICD shocks in patients with Brugada syndrome.

Authors:  Christian Veltmann; Juergen Kuschyk; Rainer Schimpf; Florian Streitner; Nina Schoene; Martin Borggrefe; Christian Wolpert
Journal:  Clin Res Cardiol       Date:  2009-09-16       Impact factor: 5.460

6.  Performance of an ICD algorithm to detect lead noise and reduce inappropriate shocks.

Authors:  Scott Beau; Stephen Greer; Christopher R Ellis; Jeffrey Keeney; Shubha Asopa; Edith Arnold; Avi Fischer
Journal:  J Interv Card Electrophysiol       Date:  2016-01-06       Impact factor: 1.900

7.  Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II.

Authors:  Katia Noyes; Ethan Corona; Peter Veazie; Andrew W Dick; Hongwei Zhao; Arthur J Moss
Journal:  Am J Cardiovasc Drugs       Date:  2009       Impact factor: 3.571

8.  Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.

Authors:  Nitesh Sood; Firas Al Badarin; Matthew Parker; Raja Pullatt; Arnold F Jacobson; Timothy M Bateman; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-07-18       Impact factor: 5.952

9.  Predictors of implantable cardioverter defibrillator shocks during the first year.

Authors:  Cynthia M Dougherty; Jim Hunziker
Journal:  J Cardiovasc Nurs       Date:  2009 Jan-Feb       Impact factor: 2.083

10.  Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population.

Authors:  Anniken Hamang; Geir Egil Eide; Karin Nordin; Berit Rokne; Cathrine Bjorvatn; Nina Øyen
Journal:  BMC Med Genet       Date:  2010-02-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.